|
November 22, 2021
|
Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer
|
|
|
November 19, 2021
|
Connect Biopharma Completes Enrollment of CBP-307 Global Phase 2 Clinical Trial in Moderate-to-Severe Ulcerative Colitis
|
|
|
November 18, 2021
|
Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis
|
|
|
November 11, 2021
|
Connect Biopharma to Participate at Upcoming Conferences
|
|
|
October 19, 2021
|
Connect Biopharma to Participate at the Jefferies Virtual China Biotech Summit
|
|
|
September 8, 2021
|
Connect Biopharma Announces First Subject Dosed in Phase 2 Trial Evaluating CBP-201 in Adult Patients with Chronic Rhinosinusitis with Nasal Polyps
|
|
|
September 2, 2021
|
Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Atopic Dermatitis
|
|
|
August 31, 2021
|
Connect Biopharma Provides Business Update and Reports First Half 2021 Financial Results
|
|
|
August 25, 2021
|
Connect Biopharma to Host First Half 2021 Financial Results Conference Call on September 1, 2021
|
|
|
August 23, 2021
|
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
|
|
